Mehrnoosh Doroudchi
Overview
Explore the profile of Mehrnoosh Doroudchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doroudchi M, Fouladseresht H
Front Aging
. 2025 Feb;
6:1560009.
PMID: 39981410
No abstract available.
2.
Zare A, Khosropanah S, Daryabor G, Doroudchi M
BMC Endocr Disord
. 2024 Aug;
24(1):162.
PMID: 39198757
Background: Type 2 diabetes mellitus, one of the most prevalent metabolic disorders worldwide, is closely linked with an enhanced risk of atherosclerosis. However, the molecular mechanism of this linkage is...
3.
Talepoor A, Doroudchi M
Immun Inflamm Dis
. 2024 Mar;
12(3):e1209.
PMID: 38456619
Background: Immunosenescence is a multifactorial stress response to different intrinsic and extrinsic insults that cause immune deterioration and is accompanied by genomic or epigenomic perturbations. It is now widely recognized...
4.
Rastegari B, Talepoor A, Khosropanah S, Doroudchi M
ACS Omega
. 2024 Jan;
9(1):658-674.
PMID: 38222576
Atherosclerosis, a leading cause of mortality worldwide, involves various subsets of macrophages that contribute to its initiation and progression. Current treatment approaches focus on systemic, long-term administration of cholesterol-lowering antioxidants...
5.
Torki E, Gharezade A, Doroudchi M, Sheikhi S, Mansury D, Sullman M, et al.
Clin Exp Med
. 2023 Sep;
23(7):3299-3319.
PMID: 37697158
The immune system is tightly regulated to prevent immune reactions to self-antigens and to avoid excessive immune responses during and after challenges from non-self-antigens. Inhibitory immune checkpoints (IICPs), as the...
6.
Mashhadi N, Kasraian L, Ghoddusi Johari H, Hosseinzadeh A, Kheshtchin N, Doroudchi M
Iran J Immunol
. 2023 Aug;
20(3):262-275.
PMID: 37647581
Background: Buerger's disease, also known as Thromboangiitis Obliterans (TAO), is a progressive, inflammatory vascular disease with unknown etiology. Objective: To address the degree of T cell immunosenescence in this inflammatory...
7.
Doroudchi M, Kalantar K
Endocr Metab Immune Disord Drug Targets
. 2022 Oct;
22(12):1147-1148.
PMID: 36268545
No abstract available.
8.
Talepoor A, Doroudchi M
Front Immunol
. 2022 Sep;
13:945016.
PMID: 36059478
Immune system is a versatile and dynamic body organ which offers survival and endurance of human beings in their hostile living environment. However, similar to other cells, immune cells are...
9.
Vakili M, Faghih Z, Sarvari J, Doroudchi M, Hosseini S, Kabelitz D, et al.
Immunol Res
. 2022 Apr;
70(4):469-480.
PMID: 35445310
Despite the availability of an effective vaccine and antiviral treatments, hepatitis B is still a global public health problem. Hepatitis B vaccination can prevent the disease. Vaccination induces long-lasting protective...
10.
Talepoor A, Rastegari B, Kalani M, Doroudchi M
Int Immunopharmacol
. 2021 Nov;
101(Pt A):108295.
PMID: 34735917
Toll-like receptors (TLRs) are among the players of inflammation during atherosclerosis. We assessed the effects of Eritoran, a TLR-4 antagonist, on lipopolysaccharide (LPS)-induced cytokines production by Peripheral Blood Mononuclear Cells...